Stimulation of β1-integrin function by epidermal growth factor and heregulin-β has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase

Molecular Biology of the Cell

Volumn 10, Issue 9, 1999, Pages 2861-2878

  Adelsman, Margaret A ^a,b   McCarthy, James B ^a,b   Shimizu, Yoji ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; INTEGRIN; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; BETA1 INTEGRIN; CARRIER PROTEIN; COLLAGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLYCOPROTEIN; HEREGULIN BETA1; LAMININ; LIGAND; ONCOPROTEIN;

ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CHEMOTAXIS; DIMERIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD29; BREAST NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL MOVEMENT; COLLAGEN; DIMERIZATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GLYCOPROTEINS; HUMANS; LAMININ; LIGANDS; NEUREGULIN-1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032586952     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.9.2861     Document Type: Article

References (83)

1. Adam, L., Vadlamudi, R., Kondapaka, S.B., Chernoff, J., Mendelsohn, J., and Kumar, R. (1998). Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 273, 28238-28246.
2. Akiyama, S.K., Larjava, H., and Yamada, K.M. (1990). Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells. Cancer Res. 50, 1601-1607.
3. Albelda, S.M. (1993). Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68, 4-17.
4. Alroy, I., and Yarden, Y. (1997). The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410, 83-86.
5. Aplin, A.E., Howe, A., Alahari, S.K., and Juliani, R.L. (1998). Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50, 197-263.
6. Arcaro, A., and Wymann, M.P. (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301.
7. Arroyo, A.G., Sanchez-Mateos, P., Campanero, M.R., Martin-Padura, I., Dejana, E., and Sanchez-Madrid, F. (1992). Regulation of the VLA integrin-ligand interactions through the β1 subunit. J. Cell Biol. 117, 659-670.
8. Baulida, J., Kraus, M.H., Alimandi, M., Di Fiore, P.P., and Carpenter, G. (1996). All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271, 5251-5257.
9. Carpenter, C.L., and Cantley, L.C. (1996). Phosphoinositide kinases. Curr. Opin. Cell Biol. 8, 153-158.
10. Carraway, K.L., III, Soltoff, S.P., Diamonti, A.J., and Cantley, L.C. (1995). Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem. 270, 7111-7116.
11. Chan, A.S.H., Mobley, J.L., Fields, G.B., and Shimizu, Y. (1997). CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase. J. Immunol. 159, 934-942.
12. Chen, P., Gupta, K., and Wells, A. (1994). Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol. 324, 547-555.
13. Chen, P., Xie, H., and Wells, A. (1996). Mitogenic signaling from the EGF receptor is attenuated by a phospholipase C-γ/protein kinase C feedback mechanism. Mol. Biol. Cell 7, 871-881.
14. Chen, X., Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N., Leitner, O., Ratzkin, B.J., Bacus, S.S., and Yarden, Y. (1996). An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem. 271, 7620-7629.
15. Cohen, B.D., Kiener, P.A., Green, J.M., Foy, L., Fell, P., and Zhang, K. (1996). The relationship between human epidermal growth-like factor receptor and cellular transformation in NIH3T3 cells. J. Biol. Chem. 271, 30897-30903.
16. Diamond, M.S., and Springer, T.A. (1994). The dynamic regulation of integrin adhesiveness. Curr. Biol. 4, 506-517.
17. Earp, H.S., Dawson, T.L., Li, X., and Yu, H. (1995). Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat. 35, 115-132.
18. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16, 1268-1278.
19. Falasca, M., Logan, S.K., Lehto, V.P., Baccante, G., Lemmon, M.A., and Schlessinger, J. (1998). Activation of phospholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17, 414-422.
20. Faraldo, M.M., Deugnier, M.A., Lukashev, M., Thiery, J.P., and Glukhova, M.A. (1998). Perturbation of β1-integrin function alters the development of murine mammary gland. EMBO J. 17, 2139-2147.
21. Fedi, P., Pierce, J.H., Di Fiore, P.P., and Kraus, M.H. (1994). Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguished ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol. 14, 492-500.
22. Fry, D.W., Kraker, A.J., McMichael, A., Ambrosa, L.A., Nelson, J.M., Leopold, W.R., Connors, R.W., and Bridges, A.J. (1994). A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265, 1093-1095.
23. Fujii, K. (1996). Ligand activation of overexpressed epidermal growth factor receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J. Invest. Dermatol. 107, 195-202.
24. Graus-Porta, D., Beerli, R.R., Daly, J.M., and Hynes, N.E. (1997). ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647-1655.
25. Graus-Porta, D., Beerli, R.R., and Hynes, N.E. (1995). Single-chain antibody-mediated intracellular retention of erbB-2 impairs neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol. 15, 1182-1191.
26. Guilherme, A., Torres, K., and Czech, M.P. (1998). Cross-talk between insulin receptor and integrin α5β1 signaling pathways. J. Biol. Chem. 273, 22899-22903.
27. Hamburger, A.W., and Yoo, J.Y. (1997). Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells. Anticancer Res. 17, 2197-2200.
28. Hellyer, N.J., Cheng, K., and Koland, J.G. (1998). ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem. J. 333, 757-763.
29. Huang, G.C., Ouyang, Y., and Epstein, R.J. (1998). Proxy activation of protein erbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction. Biochem. J. 331, 113-119.
30. Kapeller, R., and Cantley, L.C. (1994). Phosphatidylinositol 3-kinase. BioEssays 16, 565-576.
31. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E., and Yarden, Y. (1996). ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 15, 254-264.
32. Keely, P.J., Westwick, J.K., Whitehead, I.P., Der, C.J., and Parise, L.V. (1997). Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636.
33. Kinashi, T., Escobedo, J.A., Williams, L.T., Takatsu, K., and Springer, T.A. (1995). Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-γ1 pathways. Blood 86, 2086-2090.
34. Kinashi, T., and Springer, T.A. (1994). Steel factor and c-kit regulate cell-matrix adhesion. Blood 83, 1033-1038.
35. King, W.G., Mattaliano, M.D., Chan, T.O., Tsichlis, P.N., and Brugge, J.S. (1997). Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17, 4406-4418.
36. Kivens, W.J., and Shimizu, Y. (1999). Tracking integrin-mediated adhesion using green fluorescent protein and flow cytometry. In: Signaling through Cell Adhesion Molecules, ed. J.-L. Guan, Boca Raton, FL: CRC Press, 219-234.
37. Klapper, L.N., Vaisman, N., Hurwitz, E., Pinkas-Kramarksi, R., Yarden, Y., and Sela, M. (1998). A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks cross-talk with growth factor receptors. Oncogene 14, 2099-2109.
38. Klippel, A., Kavanaugh, W.M., Pot, D., and Williams, L.T. (1997). A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17, 338-344.
39. Kovach, N.L., Carlos, T.M., Yee, E., and Harlan, J.M. (1992). A monoclonal antibody to β1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J. Cell Biol. 116, 499-509.
40. Lemmon, M.A., and Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19, 459-463.
41. Levkowitz, G., Klapper, L.N., Tzahar, E., Freywald, A., Sela, M., and Yarden, Y. (1996). Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene 12, 1117-1125.
42. Li, J., Lin, M.L., Wiepz, G.J., Guadarrama, A.G., and Bertics, P.J. (1999). Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor. J. Biol. Chem. 274, 11209-11219.
43. Lichtner, R.B., Kaufmann, A.M., Kittmann, A., Rohde-Schulz, B., Walter, J., Williams, L., Ullrich, A., Schirrmacher, V., and Khazaie, K. (1995). Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. Oncogene 10, 1823-1832.
44. Lichtner, R.B., Wiedemouth, M., Noeske-Jungblut, C., and Schirrmacher, V. (1993). Rapid effects of EGF on cytoskeletal structures and adhesive properties of highly metastatic rat mammary adenocarcinoma cells. Clin. Exp. Metastasis 11, 113-125.
45. Mainiero, F., Pepe, A., Yeon, M., Ren, Y.L., and Giancotti, F.G. (1996). The intracellular functions of α6β4 integrin are regulated by EGF. J. Cell Biol. 134, 241-253.
46. Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
47. McCarthy, J.B., Vachhani, B., Wahl, S.M., Finbloom, D.S., and Feldman, G.M. (1997). Human monocyte binding to fibronectin enhances IFN-γ-induced early signaling events. J. Immunol. 159, 2424-2430.
48. Miyamoto, S., Teramoto, H., Gutkind, J.S., and Yamada, K.M. (1996). Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135, 1633-1642.
49. Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G., and Defilippi, P. (1998). Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17, 6622-6632.
50. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M. (1994). Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269, 3563-3567.
51. Olayioye, M.A., Graus-Porta, D., Beerli, R.R., Rohrer, J., Gay, B., and Hynes, N.E. (1998). ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol. 18, 5042-5051.
52. Pinkas-Kramarksi, R., et al. (1996). Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15, 2452-2467.
53. Pinkas-Kramarksi, R., et al. (1998). ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol. Cell. Biol. 18, 6090-6101.
54. Price, J.E., Polyzos, A., Zhang, R.D., and Daniels, L.M. (1990). Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50, 717-721.
55. Ram, T.G., Kokeny, K.E., Dilts, C.A., and Ethier, S.P. (1995). Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin like growth factor-I in human mammary epithelial cells. J. Cell. Physiol. 163, 589-596.
56. Rameh, L.E., Chen, C.S., and Cantley, L.C. (1995). Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 83, 821-830.
57. Riese, D.J., II, and Stern, D.F. (1998). Specificity within the EGF family ErbB receptor family signaling network. BioEssays 20, 41-48.
58. Schneller, M., Vuori, K., and Ruoslahti, E. (1997). αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J. 16, 5600-5607.
59. Schwartz, M.A., Schaller, M.D., and Ginsberg, M.H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Biol. 11, 549-599.
60. Serve, H., Yee, N.S., Stella, G., Sepp-Lorenzino, L., Tan, J.C., and Besmer, P. (1995). Differential roles of PI 3-kinase and kit tyrosine 821 in kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14, 473-483.
61. Shaw, L.M., Chao, C., Wewer, U.M., and Mercurio, A.M. (1996). Function of the integrin α6α1 in metastatic breast carcinoma cells assessed by expression of a dominant negative receptor. Cancer Res. 56, 959-963.
62. Shaw, L.M., Rabinovitz, I., Wang, H.H.F., Toker, A., and Mercurio, A.M. (1997). Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell 91, 949-960.
63. Shimizu, Y. (1994). Signaling to and from T cell integrins. In: The Integrin: The Biological Problems, ed. Y. Takada, Boca Raton, FL: CRC Press, 101-132.
64. Shimizu, Y., and Hunt, S.W., III. (1996). Regulating integrin-mediated adhesion: one more function for PI 3-kinase? Immunol. Today 17, 565-573.
65. Shimizu, Y., van Seventer, G.A., Morgan, K.J., and Shaw, S. (1990a). Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 345, 250-253.
66. Shimizu, Y., van Seventer, G.A., Horgan, K.J., and Shaw, S. (1990b). Roles of adhesion molecules in T cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol. Rev. 114, 109-143.
67. Stokoe, D., Stephens, L.R., Copeland, T., Gaffney, P.R.J., Reese, C.B., Painter, G.F., Holmes, A.B., McCormick, F., and Hawkins, P.T. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567-570.
68. Stroeken, P.J.M., Van Rijthoven, E.A.M., Van der Valk, M.A., and Roos, E. (1998). Targeted disruption of the β1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res. 58, 1569-1577.
69. Tan, M., Grijalva, R., and Yu, D.H. (1999). Heregulin β1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Cancer Res. 59, 1620-1625.
70. Theodorescu, D., Laderoute, K.R., and Guiding, K.M. (1998). Epidermal growth factor receptor-regulated human bladder cancer motility is in part a phosphatidylinositol 3-kinase-mediated process. Cell Growth Differ. 9, 919-928.
71. Verbeek, B.S., Adriaansen-Slot, S.S., Vroom, T.M., Beckers, T., and Rijksen, G. (1998). Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett. 425, 145-150.
72. Vlahos, C.J., Matter, W.F., Hui, K.Y., and Brown, R.F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
73. Vosseller, K., Stella, G., Yee, N.S., and Besmer, P. (1997). c-Kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol. Biol. Cell 8, 909-922.
74. Wallasch, C., Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W., and Ullrich, A. (1995). Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 14, 4267-4275.
75. Wang, F., Weaver, V.M., Petersen, O.W., Larabell, C.A., Dedhar, S., Briand, P., Lupu, R., and Bissell, M.J. (1998). Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA 95, 14821-14826.
76. Ware, M.F., Wells, A., and Lauffenburger, D.A. (1998). Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J. Cell Sci. 111, 2423-2432.
77. Woodard, A.S., García-Cardeña, G., Leong, M., Madri, J.A., Sessa, W.C., and Languino, L.R. (1998). The synergistic activity of αvβ3 integrin and PDGF receptor increases cell migration. J. Cell Sci. 111, 469-478.
78. Wyckoff, J.B., Insel, L., Khazaie, K., Lichtner, R.B., Condeelis, J.S., and Segall, J.E. (1998). Suppression of ruffling by the EGF receptor in chemotactic cells. Exp. Cell Res. 242, 100-109.
79. Xie, H., Pallero, M.A., Gupta, K., Chang, P., Ware, M.F., Witke, W., Kwiatkowski, D.J., Lauffenburger, D.A., Murphy-Ullrich, J.E., and Wells, A. (1998). EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway. J. Cell Sci. 111, 615-624.
80. c-erbB2: increased invasiveness may contribute to poor prognosis. Clin. Cancer Res. 3, 1629-1634.
81. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., and Matsuda, Y. (1993). Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846-25856.
82. Zell, T., Hunt, S.W., III, Finkelstein, L.D., and Shimizu, Y. (1996). CD28-mediated up-regulation of β1 integrin-mediated adhesion involves phosphatidylinositol 3-kinase. J. Immunol. 156, 883-886.
83. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A., and Yoshinage, S.K. (1996). Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem. 271, 3884-3890.